GCM
ABCL icon

Graham Capital Management’s AbCellera Biologics ABCL Stock Holding History

Graham Capital Management’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-112,831
Closed -$394K – 1224
2026
Q1 		$394K Sell
112,831
-145,007
-56% -$522K 0.01% 706
2025
Q4 		$882K Buy
257,838
+231,725
+887% +$1.03M 0.02% 425
2025
Q3 		$131K Sell
26,113
-116,922
-82% -$515K ﹤0.01% 1134
2025
Q2 		$491K Buy
+143,035
New +$356K 0.01% 836
2025
Q1 		– Sell
-103,610
Closed -$304K – 1256
2024
Q4 		$304K Buy
+103,610
New +$289K ﹤0.01% 930
2024
Q2 		– Sell
-47,551
Closed -$215K – 1005
2024
Q1 		$215K Sell
47,551
-27,606
-37% -$141K ﹤0.01% 877
2023
Q4 		$429K Sell
75,157
-105,232
-58% -$488K 0.01% 634
2023
Q3 		$830K Buy
180,389
+108,060
+149% +$657K 0.02% 419
2023
Q2 		$467K Sell
72,329
-401,921
-85% -$2.74M 0.01% 575
2023
Q1 		$3.58M Buy
474,250
+325,051
+218% +$2.95M 0.11% 127
2022
Q4 		$1.51M Sell
149,199
-254,972
-63% -$2.95M 0.05% 385
2022
Q3 		$4M Buy
404,171
+340,732
+537% +$3.74M 0.16% 72
2022
Q2 		$675K Buy
+63,439
New +$537K 0.03% 567
2022
Q1 		– Sell
-25,727
Closed -$367K – 874
2021
Q4 		$367K Buy
+25,727
New +$390K 0.02% 254

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Graham Capital Management's ABCL Position: Q2 2026 in Review

Graham Capital Management sold out of AbCellera Biologics (ABCL) in Q2 2026, closing a stake of 112,831 shares — an estimated $394K sold.

Graham Capital Management first reported a position in ABCL in Q4 2021 and held it in 14 quarters. The position peaked at $4M in Q3 2022. 150 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Graham Capital Management reported no remaining AbCellera Biologics position as of Q2 2026 after selling out during the quarter.
  • Graham Capital Management sold 112,831 AbCellera Biologics shares in Q2 2026, an estimated $394K.
  • Graham Capital Management first reported a position in AbCellera Biologics in Q4 2021 and held it in 14 quarters.
  • Graham Capital Management's AbCellera Biologics position peaked at $4M in Q3 2022.
  • 150 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.